1. India Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Marico Limited

Marico Limited

MARICO.BO
Marico LimitedIN flagBombay Stock Exchange
837.95
INR
-0.65
- -
1.09TMarket Cap
Marico Limited
MARICO.BO
(Bombay Stock Exchange)

Recent

price

837.95

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
25.52
32.27
35.76
36.26
44.34
46.7
45.86
48.83
56.41
56.24
61.94
73.19
75.02
74.08
83.71
105.21
105.3
Revenue per Share
2.34
2.58
3.09
3.76
4.45
5.53
6.21
6.32
8.64
7.92
9.08
9.49
10.08
11.46
12.59
13.62
13.63
Basic EPS, GAAP
-1.78
2.43
-4.37
4.52
4.7
5.57
4.37
3.02
6.98
7.95
14.46
6.85
9.58
9.55
9.29
13.64
- -
Free Cash Flow per Basic Share
0.38
0.38
0.52
1.1
2.33
3.9
3.95
4.94
5.29
7.95
7.5
9.25
4.51
9.51
3.5
7.02
- -
Dividend per Share
5.76
7.48
9.48
4.89
14.14
16.28
18.53
19.89
23.05
22.98
24.55
24.79
28.3
28.56
29.59
1
1.01
Book Value per Share
3.69
5.56
6.3
8.56
10.04
11.7
14.24
15.44
18.84
19.04
18.72
18.93
19.62
18.33
19.03
15.15
15.16
Tangible Book Value per Share
1,225
1,229
1,282
1,290
1,290
1,287
1,287
1,288
1,289
1,290
1,290
1,291
1,292
1,292
1,294
1,294
1,293
Basic Weighted Avg Shares
31,260
39,682
45,843
46,762
57,203
60,077
58,999
62,900
72,730
72,540
79,910
94,520
96,890
95,730
108,310
136,110
136,110
Sales/Revenue/Turnover
11.18
10.46
11.96
14.67
14.16
17.04
18.69
16.72
16.43
18.35
18.17
16.3
17.09
19.51
18.11
15.62
15.62
Operating Margin (%)
708
725
866
769
843
949
903
890
1,310
1,400
1,390
1,390
1,550
1,580
1,780
2,020
2,020
Depreciation Expense
2,864
3,171
3,959
4,854
5,734
7,115
7,986
8,140
11,140
10,210
11,720
12,250
13,020
14,810
16,290
17,620
17,620
Net Income, GAAP
22.58
19.55
26.49
27.42
28.82
29.69
29.4
25.96
10.02
24.09
21.27
21.61
24.15
22.46
21.64
20.38
20.38
Effective Tax Rate (%)
9.16
7.99
8.64
10.38
10.02
11.84
13.54
12.94
15.32
14.07
14.67
12.96
13.44
15.47
15.04
12.95
12.95
Profit Margin (%)
2,938
4,043
3,485
5,031
7,002
7,931
11,403
13,020
14,760
13,960
13,230
13,520
13,910
15,590
26,220
17,590
17,590
Working Capital
3,817
3,907
4,326
2,515
1,684
- -
- -
200
1,650
1,540
1,300
910
930
1,040
1,240
1,270
1,270
LT Debt
9,374
11,679
20,166
13,964
18,141
20,317
23,390
25,350
29,870
30,360
32,580
34,050
39,560
41,690
42,660
44,940
44,940
Total Equity
19.18
18.25
16.68
20.08
27.09
31.43
30.96
28.2
33.2
28.02
30.65
31.1
29.32
30.85
31.87
33.81
33.81
Return on Invested Capital (%)
29.54
20.61
21.47
27.96
32.62
30.66
31.23
29.32
35.16
29.15
32.35
32.55
32.03
33.36
35.58
62.13
62.13
Return on Capital (%)
74.7
39.02
37.09
52.6
46.72
36.31
35.66
32.92
40.26
34.4
38.23
38.47
37.98
40.33
43.34
89.03
89.03
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
4,510
- -
4,300
LT Borrowings
- -
- -
- -
LT Finance Leases
1,240
- -
1,270
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,295
- -
1,296
Market Capitalization
902,854
971,569
951,684

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
53,930
- -
58,600
Cash, Cash Equivalents & STI
16,910
- -
24,470
Accounts Receivable, Net
16,660
- -
13,040
Inventories
15,980
- -
16,110
Total Current Liabilities
28,370
- -
41,010
Payables & Accruals
- -
- -
- -
ST Debt
4,510
- -
4,300
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.4%
6.75%
5.34%
Free Cash Flow
20.61%
6.27%
46.84%
Net Income, GAAP
10.02%
8.54%
8.16%
Sales/Revenue/Turnover
8.88%
11.68%
25.67%
Total Cash Common Dividend
19.89%
24.12%
100.44%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
24,770
24,760
24,220
21,980
95,730
2025
26,430
26,640
27,940
27,300
108,310
2026
32,590
34,820
35,370
33,330
136,110

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3.3
2.73
2.97
- -
11.46
2025
3.6
3.26
3.08
2.65
12.59
2026
3.9
3.24
3.45
3.04
13.62

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
9.51
2025
- -
- -
- -
- -
3.5
2026
- -
- -
- -
- -
7.02
Similar Companies
Mannatech, Incorporated (MTEX)
Pola Orbis Holdings Inc. (PORBF)
Grand Hall Enterprise Co., Ltd. (8941.TWO)
APR Co., Ltd. (278470.KS)
Pigeon Corporation (7956.T)
Culti Milano S.p.A. (CULT.MI)
Business
Marico Limited (MARICO:NSI) is an India-based multinational consumer goods company that manufactures and markets a broad portfolio of products in the beauty, wellness, health, and personal care categories; its core offerings include coconut oils such as Parachute and Parachute Advansed, value-added hair oils and serums under brands like Hair & Care, Nihar Naturals, Livon, and Parachute Gold, hair care solutions including shampoos, dyes, relaxers, and conditioners via HairCode and Ôliv, edible oils and healthy foods from Saffola featuring blended refined oils, oats, masala oats, and salt, skin care products like Parachute Advansed Body Lotion, Pure Sense, and Coco Soul, male grooming ranges encompassing Set Wet deodorants, gels, sprays, waxes, and Studio X shampoos, facewashes, and soaps, anti-lice treatments under Mediker, fabric care with Revive starch, and emerging wellness brands such as Beardo, Just Herbs, True Elements, Plix, and Coco Soul Foods; internationally, it offers brands like Fiancee, Caivil, Hercules, Black Chic, Code 10, Ingwe, X-Men, Thuan Phat, and Isoplus across hair styling, grooming, and care segments. Founded in 1988 and headquartered at 7th Floor, Grande Palladium, 175 CST Road, Kalina, Santacruz East, Mumbai, India, the company operates in over 25 countries spanning India, Southeast Asia including Bangladesh, Malaysia, and Vietnam, the Middle East, Egypt, North Africa, and South Africa, with manufacturing facilities in India at locations such as Puducherry, Perundurai, Kanjikode, Jalgaon, Paldhi, Dehradun, Baddi, and Paonta Sahib, serving diverse consumer segments from mass-market households to premium wellness seekers through an extensive distribution network. In recent developments, Marico completed the acquisition of the remaining 46.02% stake in HW Wellness Solutions Private Limited, maker of True Elements health foods, in October 2025 for up to INR 138 crore, making it a wholly-owned subsidiary following an initial agreement in September 2025; it raised its stake in Satiya Nutraceuticals to 60% on a fully diluted basis by May 2025 through an additional 8.8% acquisition; and expanded its transportation infrastructure via a multi-million-dollar contract with SemiCab in November 2025, scaling from a pilot to nationwide operations for enhanced efficiency after four prior such agreements, while unveiling an ambitious growth plan targeting INR 20,000 crore revenue by 2030 with double-digit EBITDA growth and 200-250 basis points margin expansion guided for the second half of FY26.